Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1,1-Dimethylethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate → 4-(8-Morpholino-2-(2-(quinolin-2-yl)ethyl)imidazo[1,2-a]pyrazin-5-yl)benzoic acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1,1-Dimethylethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | HCID 4376766 | — |
| 반응물 | 4-(5-Bromo-2-(2-(quinolin-2-yl)ethyl)imidazo[1,2-a]pyrazin-8-yl)morpholine | HCID 117727895 | — |
| 생성물 | 4-(8-Morpholino-2-(2-(quinolin-2-yl)ethyl)imidazo[1,2-a]pyrazin-5-yl)benzoic acid | HCID 86345901 | — |
반응 단계
Compound 58a was prepared from compound 3a and 4-(tert-butoxycarbonyl)phenylboronic acid pinacol ester using the methods described in Example 57, Step A.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09249163B2 |
| 출처 데이터셋 | uspto-grants-2016_02 |
| ORD ID | ord-7dded87606e944baac23b4ca6eb627c6 |
| 출처 메모 | uspto-grants-2016_02 |